Literature DB >> 26446738

Association between sensory dysfunction and pain 1 week after breast cancer surgery: a psychophysical study.

K G Andersen1,2, H M Duriaud1, E K Aasvang1, H Kehlet1.   

Abstract

BACKGROUND: Breast cancer patients treated with axillary lymph node dissection (ALND) have a higher risk of both acute and persistent pain than those treated with sentinel lymph node biopsy (SLNB). This could be attributed to a higher risk of nerve injury with ALND. We hypothesized that (1) pain patients have more pronounced sensory dysfunction than pain-free patients, (2) ALND have more sensory dysfunction and pain than SLNB patients and (3) patients with preserved intercostobrachial nerve (ICBN) preservation have less sensory dysfunction compared to a sectioned ICBN.
METHODS: Twenty-seven patients treated with ALND and 27 with SLNB examined with a standardized Quantitative Sensory Testing (QST) protocol, including sensory mapping, mechanical and thermal thresholds, as well as recording intraoperative ICBN handling and pain status 1 week post-operative.
RESULTS: The area of cold hypoaesthesia was significantly associated with movement-related pain (P = 0.004), with a similar tendency for warmth (P = 0.018) and brush (P = 0.030) hypoaesthesia areas. 14 (26%) of the patients had moderate/severe pain at rest and 13 (24%) during movement without differences between ALND and SLNB, but ALND was associated with more sensory dysfunction than SLNB. Patients with sectioned ICBN reported lower pain intensity than those with preserved ICBN (P = 0.005), but without differences in sensory dysfunction.
CONCLUSION: Pain was increased in patients having larger areas of hypoaesthesia and reduced in patients where ICBN-section was done. Sensory dysfunction was related to extent of axillary surgery, but not with ICBN handling. Our data suggest that acute pain after breast cancer surgery may be related to nerve injury.
© 2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26446738     DOI: 10.1111/aas.12641

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

1.  Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators.

Authors:  Kristin L Schreiber; Nantthansorn Zinboonyahgoon; K Mikayla Flowers; Valerie Hruschak; Kara G Fields; Megan E Patton; Emily Schwartz; Desiree Azizoddin; Mieke Soens; Tari King; Ann Partridge; Andrea Pusic; Mehra Golshan; Rob R Edwards
Journal:  Ann Surg Oncol       Date:  2021-01-15       Impact factor: 5.344

2.  Sensory Changes and Postmastectomy Pain Following Preservation of Intercostobrachial Nerve in Breast Cancer Surgery: a Prospective Randomized Study.

Authors:  Navneet Kaur; Ram Kumar; Ayush Jain; Ashok Kumar Saxena
Journal:  Indian J Surg Oncol       Date:  2020-09-05

3.  Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition.

Authors:  Noud van Helmond; Monique A Steegers; Gertie P Filippini-de Moor; Kris C Vissers; Oliver H Wilder-Smith
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 4.  Origin, Branching, and Communications of the Intercostobrachial Nerve: a Meta-Analysis with Implications for Mastectomy and Axillary Lymph Node Dissection in Breast Cancer.

Authors:  Brandon Michael Henry; Matthew J Graves; Jakub R Pękala; Beatrice Sanna; Wan Chin Hsieh; R Shane Tubbs; Jerzy A Walocha; Krzysztof A Tomaszewski
Journal:  Cureus       Date:  2017-03-17

5.  Pain, numbness, or both? Distinguishing the longitudinal course and predictors of positive, painful neuropathic features vs numbness after breast cancer surgery.

Authors:  K Mikayla Flowers; Meghan Beck; Carin Colebaugh; Simon Haroutounian; Robert R Edwards; Kristin L Schreiber
Journal:  Pain Rep       Date:  2021-11-22

6.  Changes in Pain Sensitivity in Treatment for Breast Cancer: A 12-Month Follow-Up Case Series.

Authors:  Laura Lorenzo-Gallego; Beatriz Arranz-Martín; Helena Romay-Barrero; Virginia Prieto-Gómez; Enrique Lluch; María Torres-Lacomba
Journal:  Int J Environ Res Public Health       Date:  2022-03-29       Impact factor: 3.390

7.  AMAZONE: prevention of persistent pain after breast cancer treatment by online cognitive behavioral therapy-study protocol of a randomized controlled multicenter trial.

Authors:  Anne Lukas; Maurice Theunissen; Dianne de Korte-de Boer; Sander van Kuijk; Lotte Van Noyen; Walter Magerl; Werner Mess; Wolfgang Buhre; Madelon Peters
Journal:  Trials       Date:  2022-07-25       Impact factor: 2.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.